We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+19.36%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$95.4M
AUM Growth
+$5.28M
(+5.9%)
Cap. Flow
-$3.93M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
118
New
12
Increased
17
Reduced
46
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vericel Corp
VCEL
|
+$1.17M |
| 2 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.02M |
| 4 |
ATHX
Athersys, Inc. Common Stock
ATHX
|
+$556K |
| 5 |
Veracyte
VCYT
|
+$506K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CryoPort
CYRX
|
+$1.36M |
| 2 |
JetBlue
JBLU
|
+$1.05M |
| 3 |
AtriCure
ATRC
|
+$959K |
| 4 |
NCR Voyix
VYX
|
+$854K |
| 5 |
SNAK
Inventure Foods, Inc.
SNAK
|
+$705K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.84% |
| 2 | Technology | 9.27% |
| 3 | Industrials | 8.69% |
| 4 | Communication Services | 3.79% |
| 5 | Financials | 2.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
XPO
XPO
$23.7B
| $237K | 0.25% |
10,120
-960
| -9% | -$20.1K |
|
77
Intel
INTC
$430B
| $232K | 0.24% |
6,100
-350
| -5% | -$12.4K |
|
78
Advanced Micro Devices
AMD
$724B
| $223K | 0.23% |
+17,500
| New | +$228K |
|
79
Baxter International
BAX
$12.7B
| $220K | 0.23% |
3,500
| – | – |
|
|
BREW
80
DELISTED
Craft Brew Alliance, Inc.
BREW
| $220K | 0.23% |
12,550
| – | – |
|
|
CEMI
81
DELISTED
Chembio diagnostics, Inc.
CEMI
| $220K | 0.23% |
35,500
-10,950
| -24% | -$67.4K |
|
|
MNDT
82
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $214K | 0.22% |
+12,735
| New | +$196K |
|
|
CASC
83
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $210K | 0.22% |
51,313
-816
| -2% | -$3.12K |
|
84
Boston Scientific
BSX
$68.7B
| $204K | 0.21% |
+7,000
| New | +$193K |
|
85
Codexis
CDXS
$161M
| $200K | 0.21% |
30,000
| – | – |
|
|
AMRN
86
Amarin Corp
AMRN
$303M
| $174K | 0.18% |
2,480
+405
| +20% | +$28.7K |
|
87
Option Care Health
OPCH
$3.77B
| $151K | 0.16% |
13,750
-3,875
| -22% | -$43.8K |
|
88
Ring Energy
REI
$310M
| $145K | 0.15% |
+10,000
| New | +$129K |
|
|
YUMA
89
DELISTED
Yuma Energy Inc
YUMA
| $143K | 0.15% |
+10,000
| New | +$225K |
|
90
Altimmune
ALT
$580M
| $116K | 0.12% |
1,660
-37
| -2% | -$2.75K |
|
|
GWGH
91
DELISTED
GWG Holdings, Inc
GWGH
| $105K | 0.11% |
+10,400
| New | +$108K |
|
|
MMAT
92
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $97K | 0.1% |
388
| – | – |
|
93
Nortech Systems
NSYS
$39.4M
| $96K | 0.1% |
28,500
| – | – |
|
94
BioLife Solutions
BLFS
$1.54B
| $86K | 0.09% |
15,000
+5,000
| +50% | +$20.7K |
|
|
TEUM
95
DELISTED
Pareteum Corporation
TEUM
| $76K | 0.08% |
50,000
-12,000
| -19% | -$12K |
|
96
Nuwellis
NUWE
$174K
| – | – |
0
| – | – |
|
|
AIFC
97
AI Financial Corp
AIFC
$51.7M
| $52K | 0.05% |
10,000
| – | – |
|
|
PLM
98
DELISTED
PolyMet Mining Corp.
PLM
| $43K | 0.05% |
7,113
| – | – |
|
99
LiqTech
LIQT
$20.8M
| $42K | 0.04% |
3,555
-7,628
| -68% | -$88.4K |
|
|
DXTR
100
DELISTED
Dextera Surgical Inc.
DXTR
| $42K | 0.04% |
150,650
-183,333
| -55% | -$52.7K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Perkins Capital Management held 118 positions worth $95.4M, up 5.9% from $90.2M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management withdrew a net $3.93M in Q3 2017, closing 16 positions and reducing 46 holdings. Its most notable exit was JetBlue, an estimated $1.05M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Bristol-Myers Squibb worth $1.12M.
- Perkins Capital Management's largest Q3 2017 buy was Bristol-Myers Squibb: 17,525 shares worth $1.12M.
- Perkins Capital Management added most to Vericel Corp in Q3 2017, an estimated $1.17M increase.
- Perkins Capital Management's biggest Q3 2017 reduction was CryoPort, cutting an estimated $1.36M.
- Perkins Capital Management fully exited JetBlue in Q3 2017, selling an estimated $1.05M.
- Perkins Capital Management's ten largest holdings make up 39% of its $95.4M portfolio in Q3 2017.
- Perkins Capital Management opened 12 new positions and closed 16 in Q3 2017.
- Perkins Capital Management's portfolio value rose 5.9% quarter-over-quarter to $95.4M.
Based on Perkins Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.